MOSY Stock Chart & Historical Trading Data $MOSY Updated:

New Post Public Reply Private Reply Replies (0) Message Board
stockcharts
219
MOSY Stock Chart & Historical Trading Data $MOSY Updated: 02-18-2017
Last Trade: 2/17/2017
Last 3.50   
Open 2.26
Previous Close 3.50
Day High / Low 4.32 / 2.26
Year High / Low 9.00 / 1.80
Volume 8,059,434
Projected Volume 8059434 (460%)
# of Trades / Projected 18,902 / 18,902
Dividend / Yield - / 0.00%
Abnormal Activity ABNORMAL DAY UP
Abnormal Volume ABNORMAL VOLUME
Gap NONE
Candle BULLISH
Volatility Today HIGH
Volatility Yesterday MEDIUM
Price Relativity
From 40 Day High 100%
From 80 Day High 50%
From 150 Day High 44%
From 40 Day Low 184%
From 80 Day Low 184%
From 150 Day Low 184%
Pivot Analysis
Price Pivot $ 3.36
Day Resistance 1 $ 4.46
Day Support 1 $ 2.40
Day Resistance 2 $ 5.42
Day Support 2 $ 1.30
Consolidations
Short Term NO
Medium Term YES
Long Term NO
Volume Indicators
20 Day Avg Vol 1,752,468
Today / 20 Day Avg Vol ABOVE
150 Day Avg Vol 460,868
Today / 150 Day Avg Vol ABOVE
Abnormal Volume ABNORMAL VOLUME
William Volume Accumulation bullish
Volume Price Trend bullish
Momentum Indicators
10 Day Trend bullish
40 Day Trend bearish
100 Day Trend bearish
Stochastics bearish
RSI neutral
MACD bearish
Moving Average Indictors
15 Day Trend bullish
45 Day Trend bearish
100 Day Trend bearish
Mid Term Moving Average Crossover NONE
Long Term Moving Average Crossover NONE
Volatility Indicators
Abnormal Activity Today? ABNORMAL DAY UP
Volatility Index Today HIGH
Volatility Index Yesterday MEDIUM
10 Day Volatility INCREASING
20 Day Volatility DECREASING
40 Day Volatility INCREASING

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Celltrion's ZYMFENTRA Shows Efficacy in Crohn's Disease Study

Updated Category News Views 203

Celltrion's ZYMFENTRA® Demonstrates Efficacy in Crohn's Disease Celltrion, Inc. has recently published promising results from a post-hoc analysis of the LIBERTY-CD study regarding ZYMFENTRA® (infliximab-dyyb). This analysis reveals significant findings about the efficacy of ZYMFENTRA in treating Crohn's disease (CD), regardless of disease location, and it's exciting...

Continue Reading
Akamai Hits Major Milestone with FedRAMP High Ready Status

Updated Category News Views 232

Akamai Cloud Achieves FedRAMP High Ready Status CAMBRIDGE, Mass. – Akamai Technologies, Inc. (NASDAQ: AKAM), a leader in cybersecurity and cloud computing, has proudly announced its recent achievement of the FedRAMP High Ready status. This vital milestone confirms that Akamai is fully prepared to offer federal agencies cloud services that comply with the most rigorous...

Continue Reading
Sam Bankman-Fried's Letter: Claims, Allegations, and Future Hopes

Updated Category News Views 161

Sam Bankman-Fried's Explosive Revelations About FTX In a recently penned letter, former FTX founder Sam Bankman-Fried expressed a firm belief that FTX was never truly insolvent. He attributed much of the downfall of what he called a "$136 billion enterprise" to mismanagement by attorneys, laying blame for the financial struggles on those who were supposed to provide legal...

Continue Reading
Kraus Hamdani Aerospace's K1000ULE Unveils New Heights in UAVs

Updated Category News Views 151

Kraus Hamdani Aerospace's K1000ULE Achieves Remarkable Milestone Kraus Hamdani Aerospace, an innovator in autonomy and AI-driven unmanned systems, has announced the inclusion of its K1000ULE UAS in the U.S. Department of Defense's trusted Blue UAS Cleared List and Select List. This recognition marks a significant achievement in the field of unmanned aerial vehicles,...

Continue Reading
VNA & PACS Market Set to Reach $7.92 Billion by 2030

Updated Category News Views 280

Understanding the Vendor Neutral Archive (VNA) & PACS Market Growth The Vendor Neutral Archive (VNA) and Picture Archiving and Communication System (PACS) market is entering an exciting growth phase. This market, valued at approximately US$4.62 billion recently, is predicted to experience a significant uptick as it is forecasted to expand at a remarkable compound annual...

Continue Reading